Back to Search
Start Over
Molecular Mechanisms of Recombination Restriction in the Envelope Gene of the Human Immunodeficiency Virus
- Source :
- PLoS Pathogens, PLoS Pathogens, 2009, 5 (5), pp.e1000418. ⟨10.1371/journal.ppat.1000418⟩, PLoS Pathogens, Public Library of Science, 2009, 5 (5), pp.e1000418. ⟨10.1371/journal.ppat.1000418⟩, PLoS One, PLoS Pathogens, Vol 5, Iss 5, p e1000418 (2009)
- Publication Year :
- 2009
- Publisher :
- Public Library of Science, 2009.
-
Abstract
- The ability of pathogens to escape the host's immune response is crucial for the establishment of persistent infections and can influence virulence. Recombination has been observed to contribute to this process by generating novel genetic variants. Although distinctive recombination patterns have been described in many viral pathogens, little is known about the influence of biases in the recombination process itself relative to selective forces acting on newly formed recombinants. Understanding these influences is important for determining how recombination contributes to pathogen genome and proteome evolution. Most previous research on recombination-driven protein evolution has focused on relatively simple proteins, usually in the context of directed evolution experiments. Here, we study recombination in the envelope gene of HIV-1 between primary isolates belonging to subtypes that recombine naturally in the HIV/AIDS pandemic. By characterizing the early steps in the generation of recombinants, we provide novel insights into the evolutionary forces that shape recombination patterns within viral populations. Specifically, we show that the combined effects of mechanistic processes that determine the locations of recombination breakpoints across the HIV-1 envelope gene, and purifying selection acting against dysfunctional recombinants, can explain almost the entire distribution of breakpoints found within this gene in nature. These constraints account for the surprising paucity of recombination breakpoints found in infected individuals within this highly variable gene. Thus, the apparent randomness of HIV evolution via recombination may in fact be relatively more predictable than anticipated. In addition, the dominance of purifying selection in localized areas of the HIV genome defines regions where functional constraints on recombinants appear particularly strong, pointing to vulnerable aspects of HIV biology.<br />Author Summary Recombination allows mixing portions of genomes of different origins, generating chimeric genes and genomes. With respect to the random generation of new mutations, it can lead to the simultaneous insertion of several substitutions, introducing more drastic changes in the genome. Furthermore, recombination is expected to yield a higher proportion of functional products since it combines variants that already exist in the population and that are therefore compatible with the survival of the organism. However, when recombination involves genetically distant strains, it can be constrained by the necessity to retain the functionality of the resulting products. In pathogens, which are subjected to strong selective pressures, recombination is particularly important, and several viruses, such as the human immunodeficiency virus (HIV), readily recombine. Here, we demonstrate the existence of preferential regions for recombination in the HIV-1 envelope gene when crossing sequences representative of strains observed to recombine in vivo. Furthermore, some recombinants give a decreased proportion of functional products. When considering these factors, one can retrace the history of most natural HIV recombinants. Recombination in HIV appears not so unpredictable, therefore, and the existence of recombinants that frequently generate nonfunctional products highlights previously unappreciated limits of the genetic flexibility of HIV.
- Subjects :
- HIV Infections
MESH: Base Sequence
Genome
Polymerase Chain Reaction
Molecular Biology/Bioinformatics
MESH: HIV-1
Negative selection
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
lcsh:QH301-705.5
Genetics
Recombinant proteins
Recombination, Genetic
0303 health sciences
030302 biochemistry & molecular biology
Sequence analysis
env Gene Products, Human Immunodeficiency Virus
MESH: HIV Infections
Directed evolution
Virology/Virus Evolution and Symbiosis
3. Good health
MESH: RNA, Viral
Virology/Immunodeficiency Viruses
Proteome
RNA, Viral
MESH: Recombination, Genetic
Recombination
Research Article
lcsh:Immunologic diseases. Allergy
DNA recombination
Immunology
Virulence
Context (language use)
Molecular Biology/Molecular Evolution
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Biology
Microbiology
Evolutionary genetics
03 medical and health sciences
Virology
Humans
Viral evolution
Molecular Biology
Gene
DNA sequence analysis
030304 developmental biology
Molecular Biology/Recombination
MESH: Humans
Base Sequence
HIV
MESH: Polymerase Chain Reaction
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology
lcsh:Biology (General)
HIV-1
Parasitology
MESH: env Gene Products, Human Immunodeficiency Virus
lcsh:RC581-607
Subjects
Details
- Language :
- English
- ISSN :
- 15537374 and 15537366
- Volume :
- 5
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- PLoS Pathogens
- Accession number :
- edsair.doi.dedup.....d9164d0a90b7b77a7dff6bdebc438e27
- Full Text :
- https://doi.org/10.1371/journal.ppat.1000418⟩